Johnson & Johnson MEDTECH — Percent Change (as a percent) decreased by 12.7% to 18.5% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.8%, from 16.4% to 18.5%. This decline may warrant attention — for this metric, higher values are generally preferred.
Positive growth indicates expanding market share or increased demand; negative growth suggests market headwinds.
Measures the period-over-period growth rate of the MedTech segment's revenue. It provides a normalized view of performan...
Standard performance indicator used by investors to track segment momentum.
jnj_segment_medtech_percent_change_as_a_percent| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 77.4% | 14.5% | 15.1% | 4.9% | 10.8% | 37.6% | 54.4% | 47% | 1.5% | 23% | 15.6% | 26.2% | 0.8% | 16.4% | 23.5% | 21.2% | 18.5% |
| QoQ Change | — | -81.3% | +4.1% | -67.5% | +120.4% | +248.1% | +44.7% | -13.6% | -96.8% | >999% | -32.2% | +67.9% | -96.9% | >999% | +43.3% | -9.8% | -12.7% |
| YoY Change | — | — | — | -93.7% | -25.5% | +149.0% | >999% | +335.2% | — | -38.8% | -71.3% | -44.3% | -46.7% | -28.7% | +50.6% | -19.1% | +12.8% |